Form 8-K - Current report:
SEC Accession No. 0001193125-24-263406
Filing Date
2024-11-21
Accepted
2024-11-21 16:10:59
Documents
13
Period of Report
2024-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d847442d8k.htm   iXBRL 8-K 33331
  Complete submission text file 0001193125-24-263406.txt   156952

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20241115.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20241115_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20241115_pre.xml EX-101.PRE 11263
15 EXTRACTED XBRL INSTANCE DOCUMENT d847442d8k_htm.xml XML 3630
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 241484473
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)